Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Fonteyne Paul R.

SEC-identified person · CIK 1727550 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Amylyx Pharmaceuticals, Inc. AMLX Director filed 2022–2026
Apellis Pharmaceuticals, Inc. APLS Director filed 2020–2026
Covetrus, INC. CVET Director filed 2021–2022
Gelesis Holdings, INC. NYSE: GLS Director filed 2022–2022
Amag Pharmaceuticals, INC. AVM Director filed 2019–2020
Restorbio, Inc. TORC Director filed 2018–2020

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.